PENUMBRA INC's ticker is PEN and the CUSIP is 70975L107. A total of 346 filers reported holding PENUMBRA INC in Q4 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,218,404 | +116.1% | 17,883 | +168.0% | 0.00% | +200.0% |
| Q1 2024 | $1,489,280 | -69.8% | 6,673 | -66.0% | 0.00% | -83.3% |
| Q4 2023 | $4,933,454 | +302.6% | 19,613 | +287.2% | 0.01% | +200.0% |
| Q3 2023 | $1,225,274 | -22.8% | 5,065 | +9.8% | 0.00% | 0.0% |
| Q2 2023 | $1,586,461 | -81.4% | 4,611 | -85.0% | 0.00% | -83.3% |
| Q1 2023 | $8,540,176 | +3184.0% | 30,644 | +2521.4% | 0.01% | – |
| Q4 2022 | $260,056 | -100.0% | 1,169 | -84.5% | 0.00% | -100.0% |
| Q3 2022 | $1,426,361,000 | +26.5% | 7,523 | -16.9% | 0.00% | 0.0% |
| Q2 2022 | $1,127,155,000 | -30.4% | 9,052 | +24.1% | 0.00% | 0.0% |
| Q1 2022 | $1,619,772,000 | -23.6% | 7,292 | -1.2% | 0.00% | -33.3% |
| Q4 2021 | $2,119,847,000 | +104.2% | 7,378 | +89.4% | 0.00% | +200.0% |
| Q3 2021 | $1,038,284,000 | -5.3% | 3,896 | -2.6% | 0.00% | 0.0% |
| Q2 2021 | $1,095,966,000 | -9.8% | 3,999 | -11.0% | 0.00% | -50.0% |
| Q1 2021 | $1,215,445,000 | +156.4% | 4,492 | +65.8% | 0.00% | +100.0% |
| Q4 2020 | $474,075,000 | +31.6% | 2,709 | +46.2% | 0.00% | 0.0% |
| Q3 2020 | $360,186,000 | +3.9% | 1,853 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $346,553,000 | +31.4% | 1,938 | +18.5% | 0.00% | 0.0% |
| Q1 2020 | $263,775,000 | -47.7% | 1,635 | -46.8% | 0.00% | 0.0% |
| Q4 2019 | $504,473,000 | -26.8% | 3,071 | -40.1% | 0.00% | 0.0% |
| Q3 2019 | $689,261,000 | +158.1% | 5,125 | +207.1% | 0.00% | 0.0% |
| Q2 2019 | $267,040,000 | +4.3% | 1,669 | -4.2% | 0.00% | 0.0% |
| Q1 2019 | $256,091,000 | +19.3% | 1,742 | -0.8% | 0.00% | 0.0% |
| Q4 2018 | $214,583,000 | -16.3% | 1,756 | +2.5% | 0.00% | – |
| Q3 2018 | $256,436,000 | +40.9% | 1,713 | +30.1% | 0.00% | – |
| Q2 2018 | $181,944,000 | -74.7% | 1,317 | -78.8% | 0.00% | -100.0% |
| Q1 2018 | $718,418,000 | +24.5% | 6,212 | +1.3% | 0.00% | 0.0% |
| Q4 2017 | $577,209,000 | +78.8% | 6,134 | +71.6% | 0.00% | 0.0% |
| Q3 2017 | $322,823,000 | +1.0% | 3,575 | -1.9% | 0.00% | 0.0% |
| Q2 2017 | $319,761,000 | +623.0% | 3,644 | +587.5% | 0.00% | – |
| Q1 2017 | $44,229,000 | -62.8% | 530 | -71.5% | 0.00% | -100.0% |
| Q4 2016 | $118,796,000 | -27.3% | 1,862 | -13.4% | 0.00% | 0.0% |
| Q3 2016 | $163,303,000 | +166.5% | 2,149 | +108.6% | 0.00% | – |
| Q2 2016 | $61,285,000 | +1245.7% | 1,030 | +940.4% | 0.00% | – |
| Q1 2016 | $4,554,000 | -91.0% | 99 | -89.4% | 0.00% | – |
| Q4 2015 | $50,366,000 | – | 936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 698,371 | $132,411,000 | 3.05% |
| OAK HARBOR WEALTH PARTNERS, LLC | 37,379 | $7,087,000 | 2.78% |
| CARRET ASSET MANAGEMENT, LLC | 88,500 | $16,780,000 | 2.50% |
| PFM Health Sciences, LP | 360,030 | $68,262,000 | 2.47% |
| Rock Springs Capital Management LP | 476,000 | $90,250,000 | 2.33% |
| PFM Health Sciences, LP | 207,500 | $39,342,000 | 1.42% |
| Affinity Asset Advisors, LLC | 25,000 | $4,740,000 | 1.32% |
| Redmile Group, LLC | 178,792 | $33,899,000 | 1.32% |
| Atika Capital Management LLC | 76,000 | $14,409,000 | 1.22% |
| Champlain Investment Partners, LLC | 804,075 | $152,453,000 | 1.04% |